Product

Cerebrospinal fluid sampling

1 clinical trial

1 indication

Indication
COVID-19
Clinical trial
Study of the Sars-Cov2 Neuroinvasiveness - COVID19
Status: Terminated, Estimated PCD: 2022-11-25